Leads Evidentis with a focus on liver and metabolic clinical trials, early-phase capability, and high-quality operational execution.

Internationally recognized hepatologist, clinical trialist and quadruple-board-certified physician (internal medicine, gastroenterology, transplant hepatology and obesity medicine).

• 4,000+ citations, reflecting broad scientific adoption and impact across liver, metabolic and
  transplant research
• H-index above 30, a level associated with sustained, high-influence scholarly contribution
• 150+ peer-reviewed publications, including multiple first- and senior-author papers
• Dozens of invited lectures, keynote presentations and international conference talks
• Multiple oral presentations at AASLD, Digestive Disease Week, ACG and other premier meetings

• Editorial Board Member – Hepatology
• Past Associate Editor – Clinical Liver Disease
• Peer reviewer for Gastroenterology, Hepatology Communications, Liver Transplantation, Clinical Gastroenterology & Hepatology and other major journals

• Principal Investigator and co-investigator for multiple industry-sponsored and NIH-funded clinical trials, and observational studies
• Steering Committee Member for:
  – AlcHepNet (Alcohol-Associated Hepatitis Network)
  – ITAALD (Integrated Therapies for Alcohol-Associated Liver Disease)
  – INTEGRATE Collaborative (Improving biopsychosocial outcomes in early liver transplantation for alcohol-associated liver disease)